Phase 4 Congenital Heart Disease Clinical Trials
5 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–5 of 5 trials
Recruiting
Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
Congenital Heart Disease in Children
Phoenix Children's Hospital166 enrolled1 locationNCT04040452
Recruiting
Phase 4
A Study of Sotatercept for Patients With Eisenmenger Syndrome or Unrepaired Shunt-Associated Pulmonary Arterial Hypertension Resistant to Vasodilator Therapy
Eisenmenger SyndromePulmonary Arterial Hypertension of Congenital Heart Disease
Kazuya Hosokawa36 enrolled10 locationsNCT07356778
Recruiting
Phase 4
Efficacy Of Sodium Glucose Transporter Inhibitor (SGLT2I) In Adult Patients With Congenital Heart Disease
Heart FailureAdult Congenital Heart Disease
Anita Saraf40 enrolled3 locationsNCT06260059
Recruiting
Phase 4
Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial
Congenital Heart DiseasePulmonary RegurgitationRepaired Tetralogy of Fallot (rTOF)+2 more
The University of Hong Kong106 enrolled1 locationNCT06668389
Completed
Phase 4
Comparison between infusion and bolus of Tranexamic acid to reduce bleeding in Cyanotic congenital heart disease surgeries.
Cyanotic congenital heart disease
Irfan Akhter60 enrolled1 locationACTRN12617001176358